APA (7th ed.) Citation

N, S., Y, N., A, T., S, S., K, T., N, O., . . . K, N. (2021). Twenty-Four-Hour Intraocular Pressure Control with Omidenepag Isopropyl 0.002% in Patients with Glaucoma and Ocular Hypertension. Dove Medical Press.

Chicago Style (17th ed.) Citation

N, Shiratori, et al. Twenty-Four-Hour Intraocular Pressure Control with Omidenepag Isopropyl 0.002% in Patients with Glaucoma and Ocular Hypertension. Dove Medical Press, 2021.

MLA (8th ed.) Citation

N, Shiratori, et al. Twenty-Four-Hour Intraocular Pressure Control with Omidenepag Isopropyl 0.002% in Patients with Glaucoma and Ocular Hypertension. Dove Medical Press, 2021.